, 455-467; doi:10.3390/nu5020455
An Extract from Wax Apple (Syzygium samarangense (Blume)
Merrill and Perry) Effects Glycogenesis and Glycolysis
Pathways in Tumor Necrosis Factor-α-Treated FL83B
*, Wen-Chang Chang
and Chiao-Li Chang
Department of Human Development and Family Studies, National Taiwan Normal University,
No. 162, Sec. 1, Heping East Road
, Taipei 10610, Taiwan
Graduate Institute of Food Science and Technology, National Taiwan University, P.O. Box 23-14,
Taipei 10672, Taiwan; E-Mails: firstname.lastname@example.org (W.-C.C.);
These two authors contributed equally to this work.
Author to whom correspondence should be addressed; E-Mail: email@example.com;
Tel.: +886-2-7734-1437; Fax: +886-2-2363-09635.
Received: 29 November 2012; in revised form: 21 January 2013 / Accepted: 4 February 2013 /
Published: 6 February 2013
Abstract: FL83B mouse hepatocytes were treated with tumor necrosis factor-α (TNF-α) to
induce insulin resistance to investigate the effect of a wax apple aqueous extract (WAE) in
insulin-resistant mouse hepatocytes. The uptake of 2-[N-(7-nitrobenz-2-oxa-1,
3-diazol-4-yl)amino]-2-deoxyglucose (2 NBDG),
-glucose derivative, was
performed, and the metabolism of carbohydrates was evaluated by examining the
expression of glycogenesis or glycolysis-related proteins in insulin-resistant hepatocytes.
The results show that WAE significantly improves the uptake of glucose and enhances
glycogen content in insulin-resistant FL83B mouse hepatocytes. The results from Western
blot analysis also reveal that WAE increases the expression of glycogen synthase (GS),
hexokinase (HXK), glucose-6-phosphate dehydrogenase (G6PD), phosphofructokinase
(PFK) and aldolase in TNF-α treated cells, indicating that WAE may ameliorate glucose
metabolism by promoting glycogen synthesis and the glycolysis pathways in
insulin-resistant FL83B mouse hepatocytes.
wax apple; insulin resistance; glucose metabolism; glycogenesis; glycolysis;
FL83B mouse hepatocytes
TNF-α, tumor necrosis factor-α; WAE, wax apple aqueous extract; 2-NBDG,
Bicarbonate buffer; GS, glycogen synthase; HXK, hexokinase; G6PD, glucose-6-phosphate
dehydrogenase; PFK, phosphofructokinase; DM, diabetes mellitus; F12K, F12 Ham Kaighn’s; FBS,
Fetal bovine serum; PBS, phosphate buffered saline; SDS, sodium dodecyl sulfate; EDTA,
ethylenediamine tetraacetic acid; PMSF, phenylmethanesulfonyl fluoride; SDS-PAGE, sodium
dodecyl sulfate polyacrylamide gel electrophoresis; PBST, phosphate buffer saline and Tween 20;
HRP, horseradish peroxidase; ECL, enhanced chemiluminescence; G6P, glucose-6-phosphate;
PP pathway, pentose phosphate pathway; NADPH, nicotinamide adenine dinucleotide phosphate
reduced; ROS, reactive oxygen species; PI3K, phosphatidylinositol-3 kinase; DHAP,
Diabetes mellitus (DM) is a metabolic disorder whose incidence is rapidly increasing. This chronic
disease is characterized by hyperglycemia resulting from deficiencies in insulin secretion and/or
insulin action . Type 2 DM is the most common form of diabetes, accounting for more than 90% of
cases. Insulin resistance is a characteristic feature of Type 2 DM .
The hyperglycemia characterizing the disease is a result of altered glucose metabolism and results in
numerous complications, such as nerve and microvascular disease.
The liver is an insulin-sensitive
organ that regulates energy homeostasis. Liver cells have been used in an in vitro
model to evaluate
and screen antihyperglycemic agents from food ingredients . In addition, in vitro hepatocytes retain
the enzyme activities characteristic of the intact in vivo liver ; thus, they may provide a suitable
model for examining liver function.
Currently, several drugs that increase insulin sensitivity are being administered clinically to
ameliorate Type 2 DM. In recent years, the search for appropriate hypoglycemic agents has been
focused on plants or herbs used in traditional medicine . Myrtaceae plants are traditionally used to
cure bronchitis, asthma, DM and inflammation by Europeans . They demonstrate potent free radical
scavenging, anti-oxidant, anti-mutagen and anticancer activities . Wax apple (Syzygium
samarangense (Blume) Merrill and Perry) belongs to the Myrtaceae plant family and is of economic
importance in Asia and Taiwan. Wax apple fruits have reportedly demonstrated antihyperglycemic
activity in alloxan-induced (Type 1 DM) diabetic mice . However, studies investigating the
association between wax apples and insulin resistance (Type 2 DM) are lacking. Moreover, the
mechanism by which wax apples alter glucose metabolism in Type 2 DM is not clearly elucidated.
The present study aimed to investigate the effect of wax apple fruit extract (WAE) on carbohydrate
metabolism in TNF-α-treated insulin-resistant FL83B mouse hepatocytes. Glucose uptake, glycogen
accumulation and the expression of proteins involved in glucose metabolism were evaluated in FL83B
cells. Additionally, the expressions of glycogenic and glycolytic enzymes were analyzed using
Western blotting to identify the mechanisms underlying glucose metabolism in FL83B cells.
2. Materials and Methods
2.1. Chemicals and Reagents
Insulin, recombinant mouse TNF-α and F12 Ham Kaighn’s modification (F12K) medium were
purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). Fetal bovine serum (FBS) was obtained
from Gemini Bio-Products (Woodland, CA, USA). The fluorescent dye 2-(N-(7-nitrobenz-2-oxa-1,
3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG) was purchased from Invitrogen (Eugene, OR, USA).
All of the chemicals used in this study were of analytical grade.
2.2. Plant Material and the Extraction, Isolation and Purification of WAE
The fruit of the wax apple (Syzygium samarangense (Blume) Merrill and Perry) was collected after
the third week of blooming in 2010, July from Shuang-Hsi Township, Taipei County, Taiwan. The
method of Shen et al.  was used to obtain WAE from unripe wax apple fruit water extract into a
freeze-dried powder for further study (Figure 1). An aliquot of 20 g reconstituted wax apple fruit
extract was run through a Sephadex LH-20 (St. Louis, MO, USA) column with 0% to 100% MeOH
(500 mL) as the eluent. The fractionated eluates in the collector from single experiments were then
pooled into S1, S2, S3 and S4 fractions according to the order of elution and the thin layer
chromatography (TLC) profile. A silica gel precoated plate (Kieselgel 60 F254, 0.20 mm, Merck,
Darmstadt, Germany) with a mobile phase of benzene:ethyl-formate:formic acid = 1:5:2 was used for
TLC analysis. Fraction S3 was run through the MCI-gel CHP 20P (2 cm × 30 cm) (Mitsubishi
Chemical Industries, Tokyo, Japan) using gradient elution with MeOH-H2O (0:100, 10:90, 20:80 and
30:70; 300 mL in each stage) to obtain fractions S-31 and S-32. Fraction S-32 was run through the
Sephadex LH-20 column (2 cm × 30 cm) using gradient elution with H2O-MeOH to obtain fractions
S-321 and S-322. Fraction S-322 was further chromatographed over an MCI-gel CHP 20P column
using gradient elution with H2O-MeOH to obtain fraction A. Every 3 mL of fraction A was collected.
Adjacent fractions were pooled based on the TLC profile and then freeze-dried as a powder
(WAE, 7 mg).
2.3. Cell Culture
The experiments were performed on mouse liver FL83B cells; a hepatocyte cell line derived from a
fetal mouse (15 day to 17 day). The cells were incubated in F12K containing 10% FBS and 1% penicillin
and streptomycin (Invitrogen Corporation, Camarillo, CA, USA) in 10 cm Petri dishes at 37 °C and
. Experiments were performed on cells that were 80% to 90% confluent.
The flow chart for fractionation of wax apple fruit water extract.
2.4. Induction of Insulin Resistance Using TNF-α and Cell Preparation
The methods were adopted from Huang et al. , with minor modifications. Briefly, the FL83B
cells were seeded in 10 cm dishes and then incubated at 37 °C for 48 h to achieve 80% confluence.
Serum-free F12K medium containing 20 ng/mL recombinant mouse TNF-α was then added before
incubating for 5 h to induce insulin resistance. The cells were then transferred to another F12K
medium containing 5 mM glucose, without (basal) or with 1000 nM insulin and 6.25 ng/mL WAE and
incubated for 3 h at 37 °C. An assay of glucose uptake was then performed.
2.5. Determination of Glycogen
The accumulation of glycogen in FL83B cells was determined after the 3 h incubation noted in
2.4 using a glycogen assay kit (Biovision Corp., Mountain View, CA, USA). Briefly, the cells were
collected, washed twice with ice-cold PBS and homogenized in 200 μL deionized water. The
homogenates were boiled for 5 min to inactivate enzymes and centrifuged at 13,000× g for 5 min to
remove the pellet. Fifty microliters of supernatant of each sample were mixed with 2 μL of Hydrolysis
Enzyme Mix in a 96-well plate, and the plate was incubated at room temperature for 10 min. A 50-μL
aliquot of the reaction mix (46 μL Development Buffer, 2 μL Development Enzyme Mix, 2 μL OxiRed
Probe) was added to each well, and the plate was incubated at room temperature for 30 min in the
dark. Absorbance at 570 nm was measured using a microplate reader (Sunrise, TECAN, Salzburg,
Austria). A standard glycogen curve (0, 0.4, 0.8, 1.2, 1.6 and 2.0 μg/well) was calculated by the
2.6. Protein Extraction from Cells
After pre-incubation in serum-free F12K medium with or without TNF-α at 37 °C for 5 h, FL83B
cells were transferred to another serum-free F12K medium with/without insulin or WAE for 3 h. The
medium was removed. The cells were washed twice with ice cold PBS and then lysed in ice cold lysis
buffer containing 20 mM Tris-HCl (pH 7.4), 1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS),
2 mM ethylenediamine tetraactic acid (EDTA), 10 mM NaF, 1 mM phenylmethanesulfonyl fluoride
(PMSF), 500 μM sodium orthovanadate and 10 μg/mL antipain. Cell lysates were sonicated 4 times
every 5 s with ice cooling and then centrifuged (13,000× g, 20 min) to recover the supernatant. The
supernatant was removed as the cell extract and stored at −80 °C for further use. The protein
concentration in the cell extract was determined using Bio-Rad protein assay dye reagent (Richmond,
2.7. Western Blot Analysis
Aliquots of the supernatant, each containing 50 μg protein, were used to evaluate the expression of
glycogen synthase (GS), hexokinase (HXK), glucose-6-phosphate dehydrogenase (G6PD),
phosphofructokinase (PFK) and aldolase. The samples were subjected to 10% sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE). The proteins were electrotransferred to a
polyvinylidene difluoride membrane. The membrane was incubated with block buffer (PBS containing
0.05% Tween-20 and 5% w/v nonfat dry milk) for 1 h, washed with PBS containing 0.05% Tween-20
(PBST) 3 times and then probed with 1:2000 diluted solutions of anti-GS (Cell Signaling Technology,
Beverly, MA, USA), 1:1000 diluted solution of anti-HXK, anti-G6PD and anti-PFK antibody (Gene
Tex, Irvine, CA, USA) overnight at 4 °C. The intensity of the blots probed with 1:4000 diluted
solution of mouse monoclonal antibody to bind actin (Gene Tex, Irvine, CA, USA) was used as the
control to ensure that a constant amount of protein was loaded into each lane of the gel. The membrane
was washed 3 times for 5 min each time in phosphate buffer saline and 0.05% Tween 20 (PBST),
shaken in a solution of horseradish peroxidase (HRP)-linked anti-mouse IgG or anti-rabbit IgG
secondary antibody, washed a further 3 times for 5 min each time in PBST and then exposed to the
enhanced chemiluminescence (ECL) reagent (Millipore) according to the manufacturer’s instructions.
The films were scanned and analyzed by using UVP Biospectrum image system (Level,
2.8. Statistical Analysis
The data were analyzed using one-way ANOVA and Duncan’s new multiple range tests.
A p-value < 0.05 was considered significant.
3.1. Effect of WAE on Glycogen Content in Insulin Resistant FL83B Mouse Hepatocytes
In mouse liver FL83B cells, exposure to insulin (1000 nM) for 3 h significantly increased glycogen
content about 5.69-fold, from 0.26 ± 0.02 μg/mg protein in the normal group to 1.74 ± 0.28 μg/mg
protein in the positive control (Figure 2). There was a 133.3% increment in glycogen in TNF-α-treated
insulin-resistant cells that were treated with WAE, as well as insulin (0.63 ± 0.55 μg/mg protein), as
compared with the cells treated with TNF-α, as well as insulin (0.27 ± 0.01 μg/mg protein) (Figure 2).
Effect of wax apple aqueous extract (WAE) on glycogen content in
TNF-α-treated FL83B mouse hepatocytes. FL83B cells were incubated in serum-free
F12 Ham Kaighn’s (F12K) medium, with or without added TNF-α (20 ng/mL), incubated
at 37 °C for 5 h, transferred to another serum-free F12K medium without (basal) or with
insulin (1000 nM), WAE (6.25 μg/mL) and then incubated for an additional 3 h. Data of
glycogen content are expressed as the mean ± SD, n = 4. Letters a~c indicate significant
differences at the 5% level. N: Normal group, cells incubated with F-12K medium.
C: Control group, cells incubated with F-12K medium containing 1000 nM insulin.
T: TNF-α treated insulin-resistant group.
WAE (6.25 ng/mL)
3.2. Glycogen Synthase Expression
The addition of insulin alone increased the GS expression level by 20.8% in normal FL83B cells
(Figure 3). The GS expression level of TNF-α-induced insulin-resistant FL83B cells decreased by
28.6% compared to that of the control group. However, WAE at a concentration of 6.25 μg/mL
increased GS expression by 51.7% in insulin-resistant FL83B mouse hepatocytes (p < 0.05) (Figure 3).
Effect of WAE on glycogen synthase expression in TNF-α-treated FL83B mouse
hepatocytes. FL83B cells were incubated in serum-free F12K medium, with or without
added TNF-α (20 ng/mL), incubated at 37 °C for 5 h, transferred to another serum-free
F12K medium with or without insulin (1000 nM), WAE (6.25 μg/mL) and then incubated
for an additional 30 min. The relative expressions of glycogen synthase in each treatment
group were calculated using actin as the standard. Letters a~d indicate significant
differences at the 5% level.
3.3. Glycolysis-Related Enzyme Expression
Figure 4 shows the effect of WAE on glucose metabolite-related enzyme expression in TNF-α-treated
FL83B cells. The results show that the expression of HXK, G6PD, PFK and aldolase in insulin
alone-treated FL83B cells increased by 9.4%, 8.7%, 5.3% and 45.1%, respectively, compared to that of
the normal group. By contrast, the HXK, G6PD and PFK expression levels of the TNF-α-treated
FL83B cells decreased by 9.8%, 29.0% and 21.4%, respectively, compared to that of the normal group
(Figure 4). However, treatment with FWFE increased expression of HXK, G6PD, PFK and aldolase by
39.2%, 101.4%, 69.5% and 40.7%, respectively, compared to the TNF-α-treated group. In addition,
treatment with WAE increased expression of HXK, G6PD, PFK and aldolase by 15.7%, 31.6%, 26.7%
and 4.1%, respectively, compared to the insulin alone-treated control group (Figure 4).
Effect of WAE on glucose metabolite-related enzymes expression in
TNF-α-treated FL83B mouse hepatocytes. FL83B cells were incubated in serum-free F12K
medium, with or without added TNF-α (20 ng/mL), incubated at 37 °C for 5 h, transferred
to another serum-free F12K medium with or without insulin (1000 nM), WAE
(6.25 μg/mL) and then incubated for an additional 30 min. The relative expressions of
hexokinase, glucose-6-phosphate dehydrogenase, phosphofructokinase and aldolase in
each treatment group were calculated using actin as the standard. Letters a~d indicate
significant differences at the 5% level.
The proinflammatory cytokine TNF-α plays a pivotal role in the pathogenesis of insulin resistance
by the impairment of insulin signal transduction in cells and animals. The possible mechanisms for
TNF-α to impair insulin signal transduction involve the downregulation of insulin receptor (IR) and
insulin receptor substrate-1 (IRS-1) expressions, the inhibition of tyrosyl phosphorylation of IR and
IRS-1, the increase in serine/threonine phosphorylation of IRS-1, the decrease in the activities of
insulin receptor kinase and protein tyrosine phosphatases (PTPs) and the inhibition of insulin
stimulated glucose transporter . In our previous study, the uptake of fluorescent dye 2-NBDG in
TNF-α-induced insulin-resistant FL83B cells decreased by 1.4% and 12.9%, respectively, compared to
those of the normal and insulin alone-treated group. However, WAE at the concentration of
6.25 ng/mL, increased glucose uptake in TNF-α-treated FL83B mouse hepatocytes . WAE might
alleviate insulin resistance in TNF-α-treated FL83B cells by activating PI3K-Akt/PKB signaling and
inhibiting inflammatory response via suppression of JNK, rather than ERK, activation .
Resurreccion-Magno et al.  investigated the hypoglycemic bioactivity of wax apple fruit in Type 1
DM mice and suggested that chalcones, an intermediate product of isoflavone biosynthesis, and
polyphenol derivatives in plants and their derivates are the main anti-diabetic components.
The liver releases glucose by hydrolyzing glycogen and uptakes glucose from the blood to maintain
blood glucose homeostasis . The modulation of glucose metabolism involves the performance of
numerous glucose regulating enzymes in the liver [11,12]. Panneerselvam and Govindaswamy 
found the activity of enzymes involved in glucose metabolism, including HXK, G6PD, PFK and GS,
were declined in diabetic rats. GS is the primary enzyme for catalyzing glycogen synthesis in the liver.
Insulin induces a series of signal transduction pathways and dephosphorylates GS, which activates this
enzyme and, consequently, increases glycogen content and reduces the blood glucose level under
normal conditions . The metabolism of glucose can be mediated by insulin through insulin signal
transduction, which stimulates the subsequent utilization of glucose and synthesis of glycogen in
cells . TNF-α may interfere with insulin signal transduction via phosphorylation of insulin
receptors, tyrosyl phosphorylation of insulin receptor substrate-1 and activation of phosphatidylinositol-3
kinase (PI3K), therefore influencing glucose metabolism [16,17]. Recently, TNF-α has been reported
to inhibit the glucose uptake ability and decrease the expression of PI3K in FL83B cells . Inhibition
of PI3K results in interference of gene modulation, glucose uptake and glycogen synthesis in HepG2
hepatoma cells . The results from this study show that TNF-α may interfere with and cause the
reduction of GS expression in the FL83B cells. WAE may increase the glycogen levels (Figure 2) and
expression of GS in insulin-resistant FL83B mouse hepatocytes (Figure 3), indicating that WAE may
improve insulin sensitivity, thus promoting the synthesis of glycogen in insulin-resistant FL83B
Most cells in the body are dependent upon a continuous supply of glucose to supply energy in the
form of ATP . Glycolysis is triggered when glucose is transported into cells. In a Type 2 DM rats
model, the activity of HXK is significantly decreased . HXK is a key enzyme for the first step of
glycolysis that catalyzes phosphorylation of glucose into glucose-6-phosphate (G6P). Insulin has been
reported to increase the activity of HXK and enhance glucose utilization in muscle cells .
Treatment with TNF-α decreased the HXK expression level in normal FL83B cells. However, WAE
increased the HXK expression level in insulin-resistant FL83B mouse hepatocytes (Figure 4A),
indicating that WAE may enhance the glycolysis pathway in insulin-resistant FL83B mouse hepatocytes.
G6PD is the rate determining step key enzyme in the pentose phosphate pathway (PP pathway) that
catalyzes glucose-6-phosphate to produce 6-phosphogluconolactone, as well as nicotinamide adenine
dinucleotide phosphate reduced (NADPH) . Environmental stresses, such as drugs, inflammatory
reactions, UV exposure, ion radiation and oxidative chemicals, may lead to the production of
substantial amounts of reactive oxygen species (ROS) and high oxidative stress and, subsequently,
inhibit G6PD activity in the PP pathway . TNF-α triggers the production of ROS and depresses the
activity of G6PD in cells . Insulin promotes the production of NADPH catalyzed by G6PD and
increases the anti-oxidative capacity in hepatocytes and adipocytes. The activity of G6PD is also
modulated by the phosphatidylinositol-3 kinase (PI3K) pathway in insulin signaling cascades, which
simultaneously regulates glucose metabolism . In this study, WAE significantly increased the
expression of G6PD in insulin-resistant FL83B hepatocytes compared to results in the control group
(Figure 4B), indicating that WAE may promote cells to go through the pentose phosphate pathway for
In contrast to glucose, fructose is entirely metabolized in the liver. PFK is the rate determining
enzyme in the first step of fructose metabolism. PFK catalyzes the phosphorylation of C-1 in
fructose-6-phosphate, causing the irreversible formation of fructose-1,6-bisphosphate and promoting
glycolysis. Strack  reported that the activity of PFK significantly decreased in tissues, including
liver, muscles and adipose of streptozotocin-induced diabetic rats. However, treatment with metformin
normalized the PFK activity in muscles and adipocytes, but partially restored PFK activity in
hepatocytes of those diabetic rats. It may be that the long-term exposure to low glucose concentrations
irreversibly inactivates glucose metabolic enzymes in liver and decreases the efficiency of glycolysis
and glycogenesis as a consequence . The activity of PFK may be regulated through cytokines or
insulin secreted from cells . Insulin increases the production of fructose-2,6-bisphosphate, a PFK
activating factor, and activates PFK . Aspirin has been recognized to effectively restore glucose
metabolism by repairing the quaternary structure of PFK in diabetic rats . The results from this
study show that WAE increased the expression of PFK in insulin-resistant FL83B (Figure 4C),
suggesting that WAE may provide a similar effect to aspirin in DM patients.
Aldolase is an essential enzyme in glycolysis, which catalyzes hexose bisphosphates (i.e.,
fructose-1,6-bisphosphate) decomposition into triose phosphates, including glyceraldehyde-3-phosphate
and dihydroxyacetone phosphate (DHAP) via a reversible aldol condensation reaction . The
activity of aldolase has been reported to be affected by cytokines and various environmental
stresses . The results from this study show that TNF-α suppresses aldolase expression; however,
WAE increases the aldolase expression of TNF-α treated cells (Figure 4D), indicating that WAE may
alleviate the damage from free radicals, such as oxidative stress or ROS, of hepatocytes caused by
TNF-α, thereby improving the metabolism of hepatic glucose.
The present study investigated the effects of WAE on the metabolism of carbohydrates in
TNF-α-induced insulin-resistant FL83B mouse hepatocytes. The results show that WAE improves
glucose uptake in TNF-α-treated FL83B cells. Furthermore, WAE increases expression of GS, HXK,
G6PD, PFK and aldolase, suggesting increased glycolysis and gluconeogenesis, and WAE increases
glycogen storage. These findings suggest that wax apple fruit may mitigate the hyperglycemia in
Type 2 DM patients; therefore, it has the potential to be developed into a functional food or dietary
supplement that prevents and/or alleviates DM. Further investigation on the purification and
identification of active compounds in WAE is currently underway in our laboratory.
Financial support (NSC 97-2313-B-214-003-MY3) from the National Science Council, the
Republic of China (Taiwan) is gratefully acknowledged. Special thanks are due to James S. B. Wu of
the Institute of Food Science and Technology at National Taiwan University for his critical
suggestions in experiments. Our gratitude also goes to the Academic Paper Editing Clinic, NTNU.
Conflict of Interest
The authors declare no conflict of interest.
1. Roa, B.K.; Sudarshan, P.R.; Rajasekhar, M.D.; Nagaraju, N.; Roa, C.A. Antidiabetic activity of
fruit in alloxan induced diabetic rats. J. Ethnopharmacol. 2003
2. Cheng, H.L.; Huang, H.K.; Chang, C.I.; Tsai, C.P.; Chou, C.H. A cell-based screening identifies
compounds from the stem of Momordica charantia that overcome insulin resistance and activate
AMP activated protein kinase. J. Agric. Food Chem. 2008, 56, 6835–6843.
3. Hengstler, J.G.; Utesch, D.; Steinberg, P.; Platt, K.L.; Diener, B.; Ringel, M.; Swales, N.; Fischer,
T.; Biefang, K.; Gerl, M.; Böttger, T.; Oesch, F. Cryopreserved primary hepatocytes as a
constantly available in vitro model for the evaluation of human and animal drug metabolism and
enzyme induction. Drug Metab. Rev. 2000, 32, 81–118.
4. Rates, S.M. Plants as source of drugs. Toxicon 2001, 39, 603–613.
5. Gurib-Fakim, A. Phytochemical screening of 38 Mauritian medicinal plants. Rev. Agric. Sucr. Ile
6. Neergheen, V.; Soobrattee, M.; Bahorun, T.; Aruoma, O. Characterization of the phenolic
constituents in Mauritian endemic plants as determinants of their antioxidant activities in vitro.
J. Plant Physiol. 2006, 163, 787–799.
7. Resurreccion-Magno, M.; Villasenor, I.; Harada, N.; Monde, K. Antihyperglycaemic flavonoids
from Syzygium samarangense (Blume) Merr. and Perry. Phytother. Res. 2005, 19, 246–251.
8. Shen, S.C.; Chang, W.C.; Chang, C.L. Fraction from wax apple [Syzygium samarangense
(Blume) Merrill and Perry] fruit extract ameliorates insulin resistance via modulating insulin
signaling and inflammation pathway in tumor necrosis factor α-treated FL83B mouse hepatocytes.
Int. J. Mol. Sci. 2012
9. Huang, D.W.; Shen, S.C.; Wu, J.S.B. Effects of caffeic acid and cinnamic acid on glucose uptake
in insulin-resistant mouse hepatocytes. J. Agric. Food Chem. 2009, 57, 7687–7692.
10. Kim, H.P.; Son, K.H.; Chang, H.W.; Kang, S.S. Anti-inflammatory plant flavonoids and cellular
action mechanism. J. Pharmacol. Sci. 2004, 96, 229–245.
11. Ferrer, J.C.; Favre, C.; Gomis, R.R.; Fernandez-Novell, J.M.; Garica-Rocha, M.; de la Iglesia, N.;
Cid, E.; Guinovart, J.J. Control of glycogen deposition. FEBS Lett. 2003, 546, 127–132.
12. Iynedjian, P.B. Molecular physiology of mammalian glucokinase. Cell. Mol. Life Sci. 2009, 66,
13. Panneerselvam, R.S.; Govindaswamy, S. Effect of sodium molybdate on carbohydrate
metabolizing enzymes in alloxan-induced diabetic rat. J. Nutr. Biochem. 2002
14. Saltiel, A.R.; Kahn, C.R. Insulin signaling and the regulation of glucose and lipid metabolism.
15. Zick, Y. Insulin resistance: A phosphorylation-based uncoupling of insulin signaling. Trends Cell
16. Cheng, J.T.; Liu, I.M. Stimulatory effect of caffeic acid on α1A-adrenoceptors to increase glucose
uptake into cultured C2C12 cells. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2000, 362, 122–127.
17. Cichy, S.B.; Uddin, S.; Danilkovich, A.; Guo, S.; Klippel, A.; Unterman, T.G. Protein kinase
B/Akt mediates effect of insulin on hepatic insulin-like growth factor-binding protein-1 gene
expression through a conserved insulin response sequence. J. Biol. Chem. 1998, 273, 6482–6487.
18. González-Espinosa, C.; Romero-Ávila, M.T.; Mora-Rodríguez, D.M.; González-Espinosa, D.;
García-Sáinz, J.A. Molecular cloning and functional expression of the guinea pig
α1A-adrenoceptor. Eur. J. Pharmacol. 2001, 426, 147–155.
19. Gropper, S.S.; Smith, J.L.; Groff, J.L. Advanced Nutrition and Human Metabolism, 5th ed.;
Wadsworth Publishing: Belmont, CA, USA, 2009; p. 72.
20. Clore, J.N.; Stillman, J.; Sugerman, H. Glucose-6-phosphate flux in vitro is increased in type 2
diabetes. Diabetes 2000, 49, 969–974.
21. Ivy, J.L.; Sherman, W.M.; Cuyler, C.L.; Katz, A.L. Exercise and diet reduce muscle insulin
resistance in obese Zucker rat. Am. J. Physiol. 1986, 251, E299–E305.
22. Abdel-Rahim, E.A.; El-Saadany, S.S.; Abo-Eytta, A.M.; Wasif, M.M. The effect of sammo
administration on some fundamental enzymes of pentose phosphate pathway and energy
metabolities of alloxanized rats. Nahrung 1992, 36, 8–14.
23. Nikolaidis, M.G.; Jamurtas, A.Z.; Paschalis, V.; Kostaropoulos, I.A.; Kladi-Skandali, A.;
Balamitsi, V.; Koutedakis, Y.; Kouretas, D. Exercise-induced oxidative stress in G6PD-deficient
individuals. Med. Sci. Sports Exerc. 2006, 38, 1443–1450.
24. Ho, H.Y.; Cheng, M.L.; Chiu, D.T. Glucose-6-phosphate dehydrogenase-from oxidative stress to
cellular functions and degenerative diseases. Redox. Rep. 2007, 12, 109–118.
25. Wagle, A.; Jivraj, S.; Garlock, G.L.; Stapleton, S.R. Insulin regulation of glucose-6-phosphate
dehydrogenase gene expression is rapamycin-sensitive and requires phosphatidylinositol 3-kinase.
J. Biol. Chem. 1998, 273, 14968–14974.
26. Strack, T. Genetics and molecular biology protein kinase C-[zeta] as an AMP-activated protein
kinase kinase kinase: The protein kinase C-[zeta]-LKB1-AMP-activated protein kinase pathway.
Drugs Today (Barc.) 2008, 44, 303–314.
27. Silva, D.D.; Zancan, P.; Coelho, W.S.; Gomez, L.S.; Sola-Penna, M. Metformin reverses
hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissue
from streptozotocin-induced diabetic mouse. Arch. Biochem. Biophys. 2010, 496, 53–60.
28. Deprez, J.; Vertommen, D.; Alessi, D.R.; Hue, L.; Rider, M.H. Phosphorylation and activation of
heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin
signaling cascades. J. Biol. Chem. 1997, 272, 17269–17275.
29. Spitz, G.A.; Furtado, C.M.; Sola-Penna, M.; Zancan, P. Acetylsalicylic acid and salicylic acid
decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase
structure and activity. Biochem. Pharmacol. 2009, 77, 46–53.
30. Yamakoshi, Y.; Nagano, T.; Hu, J.C.; Yamakoshi, F.; Simmer, J.P. Porcine dentin sialoprotein
glycosylation and glycosaminoglycan attachments. BMC Biochem. 2011, 3, 1–13.
31. Huang, Y.; Shinzawa, H.; Togashi, H.; Takahashi, T.; Kuzumaki, T.; Otsu, K.; Ishikawa, K.
Interleukin-6 down regulates expression of the aldolase B and albumin genes through a pathway
involving the activation of tyrosine kinase. Arch. Biochem. Biophys. 1995, 320, 203–209.
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license